[HTML][HTML] Causes of preanalytical interferences on laboratory immunoassays–a critical review

B Caruso, C Bovo, GC Guidi - Ejifcc, 2020 - ncbi.nlm.nih.gov
Causes of Preanalytical Interferences on Laboratory Immunoassays – A Critical Review - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

[HTML][HTML] Drug interference with biochemical laboratory tests

J Katanić, B Stanimirov, V Sekeruš, M Đanić… - Biochemia …, 2023 - hrcak.srce.hr
Sažetak Clinical laboratory practice represents an essential part of clinical decision-making,
as it influences 60-70% of medical decisions at all levels of health care. Results of …

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?

Z Cui, F Cheng, L Wang, F Zou, R Pan, Y Tian… - Frontiers in …, 2023 - frontiersin.org
Introduction: Etoposide is a broad-spectrum antitumor drug that has been extensively
studied in clinical trials. However, limited information is available regarding its real-world …

Impact of interactions between drugs and laboratory test results on diagnostic test interpretation–a systematic review

JA Van Balveren… - Clinical Chemistry and …, 2018 - degruyter.com
Intake of drugs may influence the interpretation of laboratory test results. Knowledge and
correct interpretation of possible drug-laboratory test interactions (DLTIs) is important for …

Real-time monitoring of drug laboratory test interactions: a proof of concept

JA van Balveren… - Clinical Chemistry and …, 2022 - degruyter.com
Objectives For the correct interpretation of test results, it is important to be aware of drug-
laboratory test interactions (DLTIs). If DLTIs are not taken into account by clinicians …

Drug Interactions and Their Management

S McCarthy, A Fleming - Principles and Practice of Pharmacovigilance and …, 2024 - Springer
With the increasing prevalence of polypharmacy, it is more important than ever to consider
the possibility of drug–drug interactions. A drug–drug interaction occurs when the way in …

Alterações laboratoriais dos medicamentos atuantes no sistema nervoso de uma Relação Municipal de Medicamentos Essenciais do nordeste brasileiro

LS GOMES, BR PEREIRA, LM DIAS… - Revista Brasileira de …, 2024 - rbfhss.org.br
Objective: To conduct a survey on the interference of drugs in laboratory tests that are
included in the Anatomical Therapeutic Chemical (ATC) N classification (drugs that act on …

The effect of polypharmacy on procalcitonin levels in the intensive care admission of geriatric patients with sepsis

İ Demir, İ Yılmaz - Konuralp Medical Journal, 2020 - dergipark.org.tr
Objective: Procalcitonin (PCT) is a biomarker used in early diagnosis of sepsis and gaining
more value day by day. This study aimed to research the effect of polypharmacy on PCT …

Clinical decision support system: An effective tool to detect and manage drug-laboratory interactions

M Freidooni, H Pirnejad, Z Niazkhani - Journal of Health and Biomedical …, 2021 - jhbmi.ir
Lack of proper linkage between a patient's medications and the results of laboratory tests
can lead to common medication errors called drug-laboratory interactions (DLIs). DLIs are …

Part of the validation needed for future implementation of solanidine as a biomarker for CYP2D6 activity in routine practice.

MHS Enoksen, LC Hoff - 2024 - oda.oslomet.no
Background: Solanidine, found in potatoes, has proven to be a promising dietary biomarker
for phenotyping CYP2D6 activity. Center for Psychopharmacology at Diakonhjemmet …